Clinical Trial Update: Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing exemestane with tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer; the trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Nolvadex (tamoxifen)

Snippet

Sponsor: International Collaborative Cancer Group | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN